Description
FUROSEMIDE TABLETS FOR PHARMACEUTICAL REPACKAGING PROGRAM MOD #1 DECREASES FUNDING DUE TO DAMAGED BTTLE OF FUROSEMIDE 40MG TABLETS RETURNED TO VENDOR
Base award description: FUROSEMIDE TABLETS FOR PHARMACEUTICAL REPACKAGING PROGRAM
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-09-21+$115,368= $115,368
- Mod P000012011-01-18-$8= $115,360
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-09-21 | +$115,368 | $115,368 | FUROSEMIDE TABLETS FOR PHARMACEUTICAL REPACKAGING PROGRAM |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2011-01-18 | −$8 | $115,360 | FUROSEMIDE TABLETS FOR PHARMACEUTICAL REPACKAGING PROGRAM MOD #1 DECREASES FUNDING DUE TO DAMAGED BTTLE OF FUR… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NEN9A34LRHJ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79726D0125 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36E79723D0023 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36E79722D0021 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| VA797E17A0007 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2018 |
| V797D70217 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2017 |
| VA797E17C0034 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2017 |
Other recipients under 6505 from DEPT OF VETERANS AFFAIRS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA797P16J0052 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $71,957 | FY2016 |
| VA797P16J0053 | EXCELLIUM PHARMACEUTICAL INC. | DEPT OF VETERANS AFFAIRS | $69,294 | FY2016 |
| VA797P16J0051 | AMNEAL PHARMACEUTICALS OF NEW YORK, LLC | DEPT OF VETERANS AFFAIRS | $227,935 | FY2016 |
| VA797P16J0050 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $22,663 | FY2016 |
| VA797P16J0049 | MYLAN PHARMACEUTICALS INC | DEPT OF VETERANS AFFAIRS | $32,995 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_V797D9432_3600_VA797BP0136_3600 · retrieved 2026-09-26.